Call 1-855-692-3947
Depo-Provera Lawsuit – Act Now!
What is the Depo-Provera Lawsuit?
The Depo‑Provera lawsuit refers to a large wave of U.S. product‑liability claims filed by women who say the Depo‑Provera birth‑control shot caused them to develop meningiomas, a type of brain (or spinal) tumor.
Plaintiffs allege that Pfizer (and some generic manufacturers) knew or should have known about this risk, failed to warn U.S. patients and doctors in a timely, clear way, and continued marketing the drug despite emerging scientific evidence.
Overview of the Depo-Provera Lawsuit Information
What is Depo-Provera?
Depo‑Provera is a long‑acting prescription birth‑control injection that contains medroxyprogesterone acetate (DMPA), a synthetic progestin. The shot is administered once every three months and has been widely used for decades as a convenient alternative to daily oral contraceptives. It has also been prescribed for certain gynecological conditions, such as endometriosis and menstrual disorders.
Unlike pills or patches, the hormone remains active in the body for months at a time, meaning users cannot immediately stop its effects once injected. This long‑acting design is central to the lawsuit, as plaintiffs allege that prolonged exposure to the drug’s hormone increases the risk of serious side effects and that patients were not clearly informed about those long‑term risks before receiving repeated injections.
Depo-Provera Lawsuit –
Who is eligible?
You may be eligible to pursue a Depo‑Provera lawsuit if you received the Depo‑Provera birth‑control injection (or its generic equivalents containing medroxyprogesterone acetate) and were later diagnosed with a meningioma. In general, potential claimants include women who:
-Used Depo‑Provera, Depo‑SubQ Provera 104, or a generic version of the injection
-Received two or more injections (often over months or years)
-Were diagnosed with a brain or spinal meningioma after using the drug
-Used Depo‑Provera at any point after 1992 within the United States.
